Methods to avoid infections in patients with inflammatory bowel disease

被引:51
作者
Aberra, FN
Lichtenstein, GR
机构
[1] Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
[2] Vet Affairs Med Ctr, Dept Med, Div Gastroenterol, Philadelphia, PA USA
关键词
inflammatory bowel disease; ulcerative colitis; Crohn's disease; anti-inflammatory medications; immunomodulators; infections; prevention;
D O I
10.1097/01.MIB.0000160742.91602.b7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Infections have been reported in patients with inflammatory bowel disease (IBD), especially in association with anti-inflammatory and immunomodulatory medications used to treat IBD. Unfortunately, there is a dearth of information on infectious complication risk in patients with IBD. This review describes infectious complications reported in patients with IBD and provides a framework for future studies to assess potential risk factors and incidence for infection. Recommendations are also provided for prevention of infection.
引用
收藏
页码:685 / 695
页数:11
相关论文
共 112 条
[41]   Prior diagnosis of inflammatory bowel disease is a risk factor for Aeromonas infection [J].
Haffajee, JA ;
Aberra, F ;
Nachamkin, I ;
Srinivasan, R .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10) :S249-S250
[42]   Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature [J].
Hamlin, PJ ;
Shah, MN ;
Scott, N ;
Wyatt, JI ;
Howdle, PD .
POSTGRADUATE MEDICAL JOURNAL, 2004, 80 (942) :233-235
[43]   Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial [J].
Hanauer, SB ;
Korelitz, BI ;
Rutgeerts, P ;
Peppercorn, MA ;
Thisted, RA ;
Cohen, RD ;
Present, DH .
GASTROENTEROLOGY, 2004, 127 (03) :723-729
[44]   Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].
Hanauer, SB ;
Feagan, BG ;
Lichtenstein, GR ;
Mayer, LF ;
Schreiber, S ;
Colombel, JF ;
Rachmilewitz, D ;
Wolf, DC ;
Olson, A ;
Bao, WH ;
Rutgeerts, P .
LANCET, 2002, 359 (9317) :1541-1549
[45]   RANDOMIZED CONTROLLED TRIAL OF AZATHIOPRINE WITHDRAWAL IN ULCERATIVE-COLITIS [J].
HAWTHORNE, AB ;
LOGAN, RFA ;
HAWKEY, CJ ;
FOSTER, PN ;
AXON, ATR ;
SWARBRICK, ET ;
SCOTT, BB ;
LENNARDJONES, JE .
BRITISH MEDICAL JOURNAL, 1992, 305 (6844) :20-22
[46]   6-Mercaptopurine and inflammatory bowel disease: Hidden ground for the cytomegalovirus [J].
Hookey, LC ;
Depew, W ;
Boag, A ;
Vanner, S .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 17 (05) :319-322
[47]   Prospective study of the features, indications, and surgical treatment in 513 consecutive patients affected by Crohn's disease [J].
Hurst, RD ;
Molinari, M ;
Chung, TP ;
Rubin, M ;
Michelassi, F .
SURGERY, 1997, 122 (04) :661-667
[48]   Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications [J].
Hyde, GM ;
Jewell, DP ;
Kettlewell, MGW ;
Mortensen, NJMC .
DISEASES OF THE COLON & RECTUM, 2001, 44 (10) :1436-1440
[49]  
Jansen TLTA, 1998, J INTERN MED, V244, P87
[50]  
Jarrett P, 1998, CLIN EXP DERMATOL, V23, P87